No country and no U.S. state has banned ABA therapy. The question of where ABA therapy is banned comes up often because the treatment sits in an unusual global position: mandated by insurance across the United States, largely unrecognized by public health systems in much of Europe, and targeted by organized advocacy campaigns in several countries. What actually exists is a patchwork of coverage gaps, licensure rules, and one failed federal attempt to prohibit a specific aversive device used in a small number of ABA settings.
The Closest Thing to a Ban Was Reversed in Court
In 2020, the U.S. Food and Drug Administration issued a final rule prohibiting electrical stimulation devices used for aversive conditioning on people who exhibited self-injurious or aggressive behavior. The rule was aimed at devices used at the Judge Rotenberg Educational Center in Massachusetts, the last known facility in the country still applying electric shocks as a behavior modification tool.
The prohibition did not survive. In 2021, the D.C. Circuit Court of Appeals struck down the rule in Judge Rotenberg Educational Center, Inc. v. FDA, holding that the agency had overstepped by regulating the practice of medicine rather than the device itself. The devices remain legally available. Their use is extraordinarily rare and widely condemned within the ABA profession, but no federal or state ban replaced the vacated rule.
Countries Where ABA Is Available but Not Officially Supported
Several countries have not banned ABA but have declined to include it in their national healthcare systems. Families in these places often cannot access ABA through public coverage and pay out of pocket, if they can access it at all.
Germany
A 2009 German court decision classified autism spectrum disorder as a lifelong, static condition that does not respond to intervention. Because of that ruling, German health insurance is not legally required to cover autism treatment, including ABA. The classification stands in tension with Germany’s own professional medical guidelines, which have identified behavioral interventions as the only evidence-based approach for autism.
The German Association for Behavior Analysis (ABA-D) has developed quality criteria for ABA practice and submitted them to the German Ministry of Health, seeking formal recognition of ABA as an approved therapeutic intervention. That recognition has not been granted.
United Kingdom
The UK’s National Institute for Health and Care Excellence does not explicitly recommend ABA for autism. NICE guidelines accommodate ABA-based social communication interventions but stop short of endorsing ABA as a standalone therapy. A 2021 NICE surveillance review described the evidence base for ABA as “equivocal” and issued a research recommendation rather than a clinical one. The same review found no evidence that ABA causes harm and rejected a stakeholder’s request to add a “do not use” recommendation.
Continental Europe
Across much of continental Europe, ABA exists in a regulatory gray zone. Most countries lack unified frameworks for training, credentialing, or funding ABA practitioners. A peer-reviewed analysis described the situation as a “gulf” between North America, where ABA is well-established and widely covered by insurance, and Europe, where the therapy is neither officially recognized nor systematically supported by most government health systems.
New Zealand’s Conversion Therapy Law Does Not Ban ABA
New Zealand’s Conversion Practices Prohibition Legislation Act 2022 is sometimes cited as an ABA ban. That reading overstates what the law does. The Act prohibits practices directed at changing or suppressing a person’s sexual orientation, gender identity, or gender expression. It does not mention ABA or autism.
Autistic advocacy groups in New Zealand petitioned Parliament to expand the scope to include what they called “conversion therapies targeting autistic children,” including ABA. They argued that limiting the ban to sexual orientation and gender identity, and excluding disability-related practices, was discriminatory. Parliament did not adopt the broader scope. The law as passed explicitly protects health practitioners providing “legitimate care and advice” and does not restrict ABA therapy for autism.
Where Campaigns Are Pushing for Bans
Organized efforts to ban ABA exist in several countries, and none have produced legislation.
- In Australia, advocates have pushed to stop ABA from being taught in psychology programs and to eliminate it entirely.
- In South Africa, a petition directed at Parliament calls for a nationwide ban, citing research on trauma outcomes.
- In Canada, advocacy groups have called for defunding ABA and intensive behavioral intervention centers, proposing that the money be redirected toward supports autistic people themselves prefer.
- In the United States, the “Ban ABA Initiative” and similar campaigns reflect a vocal minority position within the broader autism community.
The concerns driving these campaigns include the field’s history of aversive methods in the 1960s and 1970s, when early ABA practitioners used electric shocks and physical punishment. They also include a neurodiversity critique of modern ABA: that focusing on making autistic children appear more neurotypical can suppress natural behaviors like stimming, and that some autistic adults report lasting anxiety and difficulty recognizing their own boundaries after childhood ABA.
The United States Has Moved Toward Coverage, Not Prohibition
U.S. policy has run in the opposite direction from the advocacy campaigns. All 50 states now require private health insurance plans to provide some form of coverage for autism treatment, and the vast majority explicitly include ABA. State laws vary: some cap coverage by age, dollar amount, or number of sessions, while others impose fewer restrictions.
For children under 21, the federal Early and Periodic Screening, Diagnostic, and Treatment program requires state Medicaid agencies to cover medically necessary services. A 2014 CMS guidance clarified that states must meet these EPSDT obligations for children with autism. CMS was careful to note it was “not endorsing or requiring any particular treatment modality” and that states retain responsibility for determining medical necessity case by case. Before that clarification, many states did not believe EPSDT extended to autism treatment, and children went without coverage for years.
The federal Mental Health Parity and Addiction Equity Act separately prevents group health plans from imposing stricter financial requirements or treatment limitations on mental health benefits than on medical and surgical benefits. An insurer cannot cap ABA visits at 20 per year if comparable medical services face no such limit. Enforcement investigations by the Department of Labor and CMS have targeted plans that applied annual dollar limits, stricter copayments, or more burdensome preauthorization to behavioral health services than to medical care.
Licensure Is the Real Restriction on Who Can Deliver ABA
The most tangible legal restriction on ABA in the United States is professional licensure, not prohibition. Forty states require behavior analysts to hold a state license to practice. Requirements typically include graduate-level education, supervised clinical hours, and passage of a national certification exam. These laws protect consumers by setting minimum competency standards, and they also restrict who can legally deliver ABA services.
Ontario has taken a stricter approach. The province enacted the Psychology and Applied Behaviour Analysis Act in 2021, and it took effect July 1, 2024. The law restricts the title “Behaviour Analyst” to members of the College of Psychologists and Behaviour Analysts of Ontario. No one else may use the title or hold themselves out as qualified to practice applied behaviour analysis in the province. Ontario has not banned ABA; it has confined the practice to a defined regulatory profession.
What This Means for Families
The gap between ABA’s legal status and its public perception is wider than for almost any other therapy. In the United States, coverage mandates and licensure laws have made ABA more accessible and more regulated than at any point in its history. In much of Europe, the therapy remains in a bureaucratic limbo where it is neither endorsed nor prohibited. Advocacy movements driven largely by autistic adults continue pressing for restrictions that no legislature has yet enacted. For families deciding whether ABA is an option, the practical question is rarely whether it is banned. It is whether a specific insurance plan, government program, or national health system will pay for it, and whether a licensed provider is available to deliver it.